U.S. Water Utilities Stock News

In late February 2026, Gilat Satellite Networks announced successful 3GPP-compliant 5G Non-Terrestrial Network connectivity over a GEO satellite, alongside US$39,000,000 of new orders for its Sidewinder in-flight connectivity terminals and a US$9,000,000 satellite communications contract from Israel's Ministry of Defense. Together, these wins highlight Gilat's strengthening role in next-generation satellite communications across commercial aviation, defense, and integrated 5G...

In late February 2026, Bloom Energy reported fourth-quarter 2025 results that exceeded analyst expectations, with earnings per share of US$0.45 and revenue about 21.5% above forecasts, alongside strong backlog growth from data center and commercial customers. This performance, set against growing interest in solid oxide electrolyzer technology and policy support for low-carbon hydrogen, highlighted how Bloom’s positioning at the intersection of hydrogen and on-site power is becoming...

If you are wondering whether Hartford Insurance Group shares still offer value after a strong run, it helps to step back and look at what the current price is really implying. The stock last closed at US$141.86, with returns of 0.9% over 7 days, 5.0% over 30 days, 3.5% year to date, 20.4% over 1 year, 93.2% over 3 years and 186.4% over 5 years. This naturally raises questions about how much of the story is already priced in. Recent news around Hartford has focused on its position within the...

Q3 2025 results spotlight AI-first pivot Genpact (G) recently reported strong Q3 2025 results, putting its AI-focused shift and agentic operations in the spotlight and giving investors fresh data on how platforms like AI Maestro and key cloud partnerships are translating into business momentum. See our latest analysis for Genpact. The Q3 update comes after a mixed period for investors, with the share price at US$40.21 and a recent 7 day share price return of 7.11% contrasting with a weaker...

In late February 2026, Axsome Therapeutics reported fourth-quarter 2025 revenue of US$196 million and full-year revenue of US$638.5 million, with net losses narrowing year over year, while also settling SUNOSI patent litigation with Alkem and dosing the first patient in its Phase 3 CLARITY trial of solriamfetol in major depressive disorder with excessive daytime sleepiness. Taken together with upcoming healthcare conference presentations, these updates underscore Axsome’s efforts to both...

Autodesk (NasdaqGS:ADSK) has partnered with prosthetics company BioDapt to develop high-performance prosthetic limbs for para athletes ahead of the 2028 Los Angeles Games. The collaboration uses Autodesk’s AI-powered design tools and cloud-based manufacturing software to help speed up prosthetic design, testing, and production. The project focuses on turning athlete feedback and performance data into more tailored, competition-ready prosthetics that can be produced at scale. For investors,...

IonQ stock performance snapshot IonQ (IONQ) has been on many watchlists after a mixed stretch, with a roughly 24.6% gain over the past week, but a small decline over the past month and a larger pullback across the past 3 months. See our latest analysis for IonQ. Zooming out, IonQ’s 24.6% 7 day share price return comes after a softer patch, with a 30 day share price return of a 4.1% decline. The 1 year total shareholder return of 65.9% and very large 3 year total shareholder return suggest...

GE HealthCare Technologies (GEHC) is back in focus after securing 510(k) FDA clearance for three MRI offerings, including a helium free system, a high performance 3T scanner and an AI centered workflow platform. See our latest analysis for GE HealthCare Technologies. Despite the fresh MRI clearances and a series of recent agreements in ultrasound, imaging alliances and new credit facilities, GE HealthCare’s recent momentum has been mixed, with a 1 month share price return of 1.51% but a 1...

Hewlett Packard Enterprise (NYSE:HPE) has introduced new AI native networking and compute solutions ahead of Mobile World Congress 2026. The launch includes expanded integration of Juniper Networks technology across HPE's networking portfolio. HPE is pairing these AI focused offerings with new financing options aimed at service providers scaling AI infrastructure and modern networks. Hewlett Packard Enterprise, trading at $22.13, is putting fresh attention on AI centric networking and...

U.S. Gold Corp. recently presented at the Emerging Growth Virtual Conference on February 25, 2026, with Executive Chairman Luke Anthony Norman addressing investors. This appearance gave the company a platform to highlight its latest corporate developments and project plans directly to a broad investment audience. We’ll now explore how U.S. Gold Corp.’s Emerging Growth Virtual Conference presentation could shape its investment narrative and investor expectations. The best AI stocks today may...

Board changes put Aurora Innovation (AUR) governance in focus Aurora Innovation (AUR) is back on investor watch after director Claire D’Oyly-Hughes Johnson resigned on February 27, 2026, and Meta executive David Wehner joined the board to deepen governance and financial oversight. See our latest analysis for Aurora Innovation. The board reshuffle comes as Aurora Innovation’s share price, now at $4.75, has logged a 13.1% 1 month share price return and a 19.1% 3 month share price return, while...

PulteGroup recently presented at the 47th Annual Raymond James Institutional Investor Conference and, through Pulte Homes, has broken ground on Hilliard Isle, a US$300 million, 900-acre master-planned community in Kissimmee featuring more than 2,000 homes and extensive resort-style amenities. These developments come as PulteGroup contends with slowing orders, margin pressure, and a declining backlog, while still outperforming recent earnings expectations through what management describes as...

LKQ (LKQ) has initiated a formal review of its business after renewed pressure from activist investors, putting potential asset sales or even a full company sale on the table for shareholders. See our latest analysis for LKQ. LKQ's formal review comes after a tough run for long term holders, with a 1 year total shareholder return decline of 19.3% and a 3 year total shareholder return decline of 38.1%. At the same time, the 90 day share price return of 12.3% suggests momentum has recently...

WD-40 Company recently expanded its board of directors to 10 members by appointing Ken Plunk, a former J&J Snack Foods chief financial officer and long-time Wal-Mart executive, to serve on its Audit and Finance Committees effective February 18, 2026. This appointment brings extensive financial, international operations, and risk oversight experience to WD-40’s board, potentially strengthening governance around capital allocation, global expansion, and operational efficiency. Next, we’ll...

In February 2026, Glaukos Corporation reported past fourth-quarter and full-year 2025 results showing sales rising to US$143.12 million for the quarter and US$507.44 million for the year, alongside a larger net loss and a US$112,867,000 impairment of intangible assets, and it also issued 2026 net sales guidance of US$600 million to US$620 million. Glaukos has also filed a US$69.25 million shelf registration tied to an ESOP-related common stock offering, highlighting how the company is...

Why Armstrong World Industries is on investors’ radar right now Armstrong World Industries (AWI) has attracted fresh attention after releasing fourth quarter and full year 2025 results alongside earnings guidance for 2026, giving investors new data on both recent performance and management expectations. See our latest analysis for Armstrong World Industries. The recent guidance for 2026, dividend affirmation and senior leadership change come as the share price has pulled back, with a 7 day...

In late February 2026, AeroVironment announced a US$186 million delivery order from the U.S. Army for its next-generation Switchblade 600 Block 2 and Switchblade 300 Block 20 loitering munitions under an existing five-year, US$990 million IDIQ contract for Lethal Unmanned Systems. This marks the Army’s first procurement of AeroVironment’s upgraded Switchblade line featuring explosively formed penetrator payloads and enhanced anti-armor capabilities, reinforcing the company’s role in...

IDEAYA Biosciences recently enrolled the first patient in a Phase 1 trial of IDE034, a bispecific TOP1 antibody-drug conjugate targeting co-expressed PTK7 and B7H3 in solid tumors, triggering a US$5.00 million milestone payment to Biocytogen under their Option and License Agreement. The trial positions IDE034 as a potentially first-in-class asset with a co-expression-based targeting approach and combination plans with IDEAYA’s PARG inhibitor IDE161, aimed at enhancing selectivity and...

In February 2026, Henry Schein One announced a direct data integration between Align Technology’s iTero intraoral scanners and its Dentrix, Dentrix Ascend, and Dentally practice management platforms, while Align’s board separately adopted amended and restated bylaws allowing long-term holders of at least 25% of its shares to request special shareholder meetings. Together, the deeper integration of iTero into one of dentistry’s largest software ecosystems and the expanded shareholder meeting...

Recent Performance Snapshot Walt Disney (DIS) has seen mixed share performance recently, with about a 1.6% decline over the past day, flat movement over the past week, and a larger decline over the past month. See our latest analysis for Walt Disney. Looking beyond the recent weakness, the 1 year total shareholder return is a decline of 6.5%, while the 3 year total shareholder return is a gain of 6.1%. This suggests sentiment has been improving over a longer stretch, even as the current share...

Why Church & Dwight is on investors’ radar today Church & Dwight (CHD) is drawing fresh attention after a period in which the share price and fundamentals have moved in different directions, prompting investors to reassess how the business is currently priced. The stock has returned about 8% over the past month and roughly 24% in the past 3 months, while the 1 year total return is a 6% decline. That split between recent momentum and longer term performance often leads investors to look more...

AbbVie (NYSE:ABBV) received FDA orphan drug designation for a neuroendocrine carcinoma treatment. The company reported positive Phase 3 results for risankizumab in Crohn's disease. AbbVie announced a $380 million investment in new U.S. manufacturing facilities using advanced technologies and AI. AbbVie, trading at $234.26, has seen its share price move alongside a 14.5% return over the past year and a 167.3% return over the past five years. These recent updates touch three key areas...

In February 2026, activist investor Land & Buildings intensified pressure on First Industrial Realty Trust by publicly criticizing the board’s culture, urging governance and portfolio changes, and formally nominating its founder Jonathan Litt for election at the 2026 annual shareholder meeting. This push for boardroom reform comes just after First Industrial reported quarterly earnings and revenue that significantly exceeded analyst expectations, sharpening attention on how governance...

Why Henry Schein is on investors' radar today Henry Schein (HSIC) has drawn fresh attention after its recent trading performance, with the shares closing at $81.37 and showing positive returns over the past month and the past three months. See our latest analysis for Henry Schein. While the share price saw a 1 day decline of 1.24%, Henry Schein’s 30 day share price return of 7.80% and 1 year total shareholder return of 14.91% suggest momentum has been building recently rather than fading. If...